January 23rd, 2024 2 min read GLP-1, originally developed to treat diabetes, also works as a weight loss medication as well
The peptide can't mobilize fat when insulin is telling your body to store energy
Unlike GLP-1 medications, which primarily target metabolic and appetite pathways, CJC-1295 operates through distinct receptors and signaling cascades
Though the different dosages and types may impact the body in a variety of ways, generally, GLP-1 agonist medications may: Delay gastric emptying and slow the speed at which food leaves the stomach, and glucose may enter the blood
Oncology sales were $1.25 billion in 2021, with cell therapy sales of $871 million growing 43% compared with 2020 and Trodelvy sales of $380 million